Medicare按服务收费人群中肺癌筛查的使用情况
本研究利用2016年100% Medicare按服务收费索赔数据,评估肺癌筛查(LCS)在符合条件人群中的早期使用情况。结果显示103,892名受益人接受LCS,仅占估计符合条件人群的4.1%(95%CI 3.9%-4.3%),且存在地理和种族差异,东北部筛查率显著高于南部,非白种人筛查频率较低。
要点
- 2016年Medicare FFS人群LCS使用率低,仅4.1%符合条件者接受筛查。
- 东北部筛查率显著高于南部(调整率比1.83,95%CI 1.36-2.46)。
- 非白种人(黑人和西班牙裔)在所有地区筛查频率均低于白种人(P<.001)。
核心结论
- Medicare受益人中LCS的早期采纳率低,仅4.1%的估计符合条件人群接受筛查。
- 筛查使用存在地理和种族差异,南部地区和非白种人筛查频率较低。
研究设计与样本
- 利用美国人口普查局和CDC的人口与吸烟数据估计LCS符合条件的Medicare人群。
- 采用单变量和多变量回归分析筛查率差异,后者包括地理位置与种族/族裔的交互作用。
主要发现
- 2016年共有103,892名Medicare FFS受益人接受LCS,占估计符合条件人群的4.1%(95%CI 3.9%-4.3%)。
- 调整交互作用后,非白种人(黑人和西班牙裔)在所有美国地区的筛查频率均低于白种人(P<.001)。
- 东北部筛查率显著高于其他地区,相对南部的调整率比(95%CI)为1.83(1.36-2.46)。
临床怎么用
- 临床应关注Medicare人群中LCS的低使用率,尤其是南部地区和非白种人群体。
- 需采取措施提高LCS uptake,确保所有高风险人群一致使用筛查。
局限性
- 研究为横断面观察性设计,仅反映2016年早期使用情况,不能推断因果关系。
- 使用索赔数据可能受编码准确性影响,且符合条件人群为估计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A number of organizations, including the US Preventive Services Task Force (USPSTF), recommend lung cancer screening (LCS) with low-dose CT (LDCT) imaging for high-risk current and former smokers. In 2015, Medicare issued a decision to cover LCS as a preventive health benefit; however, utilization by the Medicare population has not been thoroughly examined. RESEARCH QUESTION: Our objective was to evaluate the early use of LCS in the Medicare fee-for-service (FFS) population and determine the relationship(s) among beneficiary sociodemographic characteristics, geographic location, and use. STUDY DESIGN AND METHODS: This cross-sectional observational study used 100% Medicare FFS claims files for Medicare beneficiaries receiving LCS between January 1, 2016 and December 31, 2016. We estimated the LCS-eligible Medicare population using population and smoking data from the US Census Bureau and Centers for Disease Control and Prevention. We assessed variation in LCS rates by beneficiary characteristics and geography, using univariate and multivariate regression, the latter also including how interactions between geographic location and race/ethnicity influence screening. RESULTS: A total of 103,892 Medicare FFS beneficiaries received LCS in 2016, comprising 4.1% (95% CI, 3.9%-4.3%) of the estimated LCS-eligible Medicare population. Accounting for the interactions between race/ethnicity and US region, nonwhite (black, Hispanic) beneficiaries in all US regions were screened with lower frequency than white beneficiaries (P < .001). Screening rates in the Northeast were significantly higher than in other regions (adjusted rate ratio [95% CI] of Northeast relative to South: 1.83 [1.36-2.46]). INTERPRETATION: The early adoption of LCS among Medicare beneficiaries was low. Our results suggest geographic and racial disparities in screening use, with populations in the South and those of nonwhite race/ethnicity being screened with lower frequency. Further work is needed to improve LCS uptake and ensure consistent use by all at-risk populations.
引用
- Tailor TD, Tong BC, Gao J, et al. Utilization of Lung Cancer Screening in the Medicare Fee-for-Service Population. Chest. 2020. PMID: 32562612. doi:10.1016/j.chest.2020.05.592
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。